D. Howe

Phase 1 and preclinical profiling of ESM‐HDAC391, a myeloid‐targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia

R. Prinjha, H. Lewis, M. Toal, 2022, British journal of clinical pharmacology.

Fetal stroke and cerebrovascular disease Advances in understanding from alloimmune thrombocytopaenia and monochorionic twins

F. Kirkham, R. Gunny, Philippa Czarpran, 2018 .

Induced CD8+FoxP3+ Treg Cells in Rheumatoid Arthritis Are Modulated by p38 Phosphorylation and Monocytes Expressing Membrane Tumor Necrosis Factor α and CD86

M. Ehrenstein, C. Notley, S. D. Ellis, 2014, Arthritis & rheumatology.

A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity

U. Müller-Ladner, Isharat Yusuf, T. Thisted, 2019, Science Translational Medicine.

Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses

Neang S. Ly, T. Mayadas, E. Grant, 2018, Annals of the Rheumatic Diseases.